SS Innovations International (SSII) Operating Margin (2022 - 2026)
SS Innovations International (SSII) reported Operating Margin of 32.78% for Q1 2026, up 8287.0% on a YoY basis from 0.39% in Q1 2025, and down 548.17% sequentially from 5.06% in Q4 2025.
SS Innovations International (SSII) Operating Margin (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Operating Margin data on file, last reported at 32.78% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 8287.0% year-over-year to 32.78%; the trailing twelve-month figure through Mar 2026 stood at 12.61% (up 5546.0% YoY), and the FY2025 full-year result was 19.29%, up 7261.0% from the prior year.
- Operating Margin eased to 32.78% in Q1 2026, from 5.06% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 0.97% in Q2 2025 to a low of 852.52% in Q4 2023.
- A 5-year average of 153.45% and a median of 84.69% in 2023 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin sank 75580 bps in 2023 and surged 82986 bps in 2024, its largest moves.
- Tracing SSII's Operating Margin over 5 years: stood at 96.72% in 2022, then slumped by 781 bps to 852.52% in 2023, then jumped by 97 bps to 22.65% in 2024, then surged by 78 bps to 5.06% in 2025, then tumbled by 548 bps to 32.78% in 2026.
- Business Quant data shows SSII's Operating Margin at 32.78% in Q1 2026, 5.06% in Q4 2025, and 14.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | -32.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.78% |
| Dec 31, 2025 | -5.06% |
| Sep 30, 2025 | -14.31% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -115.65% |
| Dec 31, 2024 | -22.65% |
| Sep 30, 2024 | -73.06% |
| Jun 30, 2024 | -90.93% |
| Mar 31, 2024 | -270.29% |
| Dec 31, 2023 | -852.52% |
| Sep 30, 2023 | -84.69% |
| Jun 30, 2023 | -274.40% |
| Mar 31, 2023 | -289.27% |
| Dec 31, 2022 | -96.72% |
| Sep 30, 2022 | -80.36% |